SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-05-023557
Filing Date
2005-02-09
Accepted
2005-02-09 16:36:59
Documents
5
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE QUARTERLY PERIOD ENDED DECEMBER 31, 2004 d10q.htm 10-Q 241764
2 WELLSTAT/REPLIGEN SETTLEMENT AGREEMENT dex101.htm EX-10.1 916556
3 REGENTS/REPLIGEN SETTLEMENT AGREEMENT dex102.htm EX-10.2 664905
4 SECTION 302 CEO AND PRESIDENT CERTIFICATION dex311.htm EX-31.1 6832
5 SECTION 906 CEO AND PRESIDENT CERTIFICATION dex321.htm EX-32.1 4171
  Complete submission text file 0001193125-05-023557.txt   1836379
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Filer) CIK: 0000730272 (see all company filings)

IRS No.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-14656 | Film No.: 05589139
SIC: 2836 Biological Products, (No Diagnostic Substances)